$Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients$

Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2021-04, Vol.100 (4), p.1111-1113
Hauptverfasser:	Zappasodi, P., Brociner, M., Merati, G., Nizzoli, M. E., Roncoroni, E., Boveri, E., Castagnola, C., Arcaini, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antineoplastic Combined Chemotherapy Protocols - toxicity Azacitidine - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Female Hematology Humans Letter to the Editor Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - pathology Male Medicine Medicine & Public Health Middle Aged Oncology Sulfonamides - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!